The results has been filter on Tags containing Healthcare / Pharmaceutical / Wellness.
ANA has found 386 results for you, in
213 ms.
Currently showing results 190 to 198.
Didn’t find what you were looking for? Try the Advanced Search!
Wernli, J. (1987a, June 15). Socioeconomic benefits of drugs. ANA - ESOMAR. Retrieved September 27, 2024, from
https://ana.esomar.org/documents/socioeconomic-benefits-of-drugs
Leroy-Sharman and Tinn (1987a, June 15). Pricing research what should we actually remeasuring?. ANA - ESOMAR. Retrieved September 27, 2024, from
https://ana.esomar.org/documents/pricing-research-what-should-we-actually-remeasuring-
Hertzman, P. (1987a, June 15). A model for a cost-benefit analysis of a new pharmaceutical. ANA - ESOMAR. Retrieved September 27, 2024, from
https://ana.esomar.org/documents/a-model-for-a-cost-benefit-analysis-of-a-new-pharmaceutical
Loreti and Racco (1987a, June 15). The structure of the costs recognized by the price formation method used for medicinal specialties in Italy. ANA - ESOMAR. Retrieved September 27, 2024, from
Linde and Abrahamson (1987a, June 15). Radar dynamics . ANA - ESOMAR. Retrieved September 27, 2024, from
https://ana.esomar.org/documents/radar-dynamics-
Montemayor-Orr, M. C. (1987a, June 15). The use of conjoint analysis in forecasting and price elasticity for a new pharmaceutical entry. ANA - ESOMAR. Retrieved September 27, 2024, from
Bouée, J. B. (1987a, June 15). Potential evolutions of medical, industrial, and distribution practices in the Japanese pharmaceutical business strategy of the Japanese government. ANA - ESOMAR. Retrieved September 27, 2024, from
Lin, L. Y. (1987a, June 15). Forecasting new over-the-counter drug sales at various price levels. ANA - ESOMAR. Retrieved September 27, 2024, from
https://ana.esomar.org/documents/forecasting-new-over-the-counter-drug-sales-at-various-price-levels
Dajda and Owen (1987a, June 15). Price sensitivity analysis in the UK pharmaceutical market. ANA - ESOMAR. Retrieved September 27, 2024, from
https://ana.esomar.org/documents/price-sensitivity-analysis-in-the-uk-pharmaceutical-market